Expression of human immunodeficiency virus type 1gaggene using genetically engineered herpes simplex virus type 1 recombinants
✍ Scribed by Angela Rösen-Wolff; Karl Raab; Lothar Zöller; Gholamreza Darai; Josef Eberle; Friedrich Deinhardt
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 638 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0920-8569
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It was proposed recently that CEM CD4-positive T cells infected chronically by herpes simplex virus type 1 (HSV-1) and human immunodeficiency virus type 1 (HIV-1) (CEM(HSV/HIV)) may be used as a model for studying HIV/HSV interactions. To ascertain whether HSV-HIV coinfection of T lymphocytes has a
Inhibitory antibodies to the reverse transcriptase (RT) of human immunodeficiency virus type-1 (HIV-1) can be used to block the life cycle of the virus. We have isolated five different human single chain Fv (ScFv) antibodies specific for HIV-1 RT from an antibody phage display library. Three of thes
## Phosphorylation of herpes simplex virus type 1 Us11 protein is independent of viral genome expression The Us11 protein is a true late gene product of herpes simplex virus type 1 (HSV-I), whose exact function is unknown but which exhibits RNA-binding properties and which is phosphorylated on ser